Related Experiment Videos
[Detecting genetic polymorphisms of CYP1 A1 and GSTM1 simultaneously with oligonucleotide microarray]
San-Zhen Liu1, Yao Li, Rong-Yu Li
1State Key Laboratory of Genetic Engineering, Institute of Genetics, College of Life Science, Fudan University, Shanghai 200043, China.
Yi Chuan Xue Bao = Acta Genetica Sinica
|November 24, 2004
Summary
Cytochrome P4501A1 and Glutathione S-transferase (GSTM1) gene variations influence smoker cancer risk. A new microarray method accurately detects these genetic variations, aiding in risk assessment for lung, esophagus, and oral cavity cancers.
Area of Science:
- Genetics and Molecular Biology
- Cancer Research
- Pharmacogenomics
Context:
- Cytochrome P4501A1 (CYP1A1) bioactivates tobacco carcinogens.
- Glutathione S-transferase mu 1 (GSTM1) null genotype affects carcinogen detoxification.
- Combined CYP1A1/GSTM1 genotypes may increase cancer risk in smokers.
Purpose:
- Develop and validate an oligonucleotide microarray for CYP1A1 and GSTM1 genotyping.
- Accurately detect single nucleotide polymorphisms (SNPs) in CYP1A1 (m1 and m2) and the GSTM1 null genotype.
- Assess the frequency of these genetic variations in a healthy population.
Summary:
- A novel microarray method was developed and validated against direct sequencing for CYP1A1 and GSTM1 genotyping.
- The study genotyped 84 healthy volunteers, finding 47.6% had the GSTM1 null genotype.
- Analysis revealed specific CYP1A1/GSTM1 haplotype frequencies, suggesting limited recombination between CYP1A1 m1 and m2 sites.
Impact:
- Provides a reliable and efficient tool for genetic screening of CYP1A1 and GSTM1.
- Contributes to understanding the genetic predisposition to smoking-related cancers.
- Facilitates further research into genotype-environment interactions in carcinogenesis.